Woodline Partners LP Acadia Pharmaceuticals Inc Transaction History

Woodline Partners LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $9.85 Million - $15.1 Million	474,159 New	474,159 $14.8 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $7.11 Million - $10.2 Million	399,450 Added 92.7%	830,355 $19.9 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $7.03 Million - $9.01 Million	430,905 New	430,905 $8.11 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $1.91 Million - $2.48 Million	135,582 Added 52.15%	395,549 $6.47 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $3.38 Million - $7.08 Million	259,967 New	259,967 $3.66 Million

Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $8.72 Million - $11.4 Million	-416,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $2.9 Million - $4.68 Million	-172,659 Reduced 29.32%	416,200 $9.71 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $1.17 Million - $1.84 Million	-74,195 Reduced 11.19%	588,859 $9.78 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $5.29 Million - $7.47 Million	272,463 Added 69.76%	663,054 $16.2 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $8.5 Million - $18.7 Million	339,678 Added 667.17%	390,591 $10.1 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $11.3 Million - $15.7 Million	-276,502 Reduced 84.45%	50,913 $2.72 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $9.68 Million - $15.2 Million	265,840 Added 431.73%	327,415 $13.5 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $2.42 Million - $3.25 Million	61,575 New	61,575 $2.99 Million

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.